Georgina Arrambide

Defining high, medium and low impact prognostic factors for developing multiple sclerosis

Mar Tintoré, Àlex Rovira, Jordi Río et al. · Brain · 2015 · 505 citations

Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study

Thaís Armangué, Gemma Olivé-Cirera, Eugenia Martínez‐Hernández et al. · The Lancet Neurology · 2020 · 314 citations

Multicentre Observational Study, Medicine, Neurological Disorder +8

Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease

Romana Höftberger, María Sepúlveda, Thaís Armangué et al. · Multiple Sclerosis Journal · 2014 · 276 citations · Full text

Association of Early Progression Independent of Relapse Activity With Long-term Disability After a First Demyelinating Event in Multiple Sclerosis

Carmen Tur, Pere Carbonell‐Mirabent, Álvaro Cobo‐Calvo et al. · JAMA Neurology · 2022 · 245 citations · Full text

Clinical Features and Risk of Relapse in Children and Adults with Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease

Álvaro Cobo‐Calvo, Anne Ruiz, Fabien Rollot et al. · Annals of Neurology · 2020 · 242 citations · Full text